Oxidative Damage and Nuclear Factor Erythroid 2-Related Factor 2 Protein Expression in Normal Skin and Keloid Tissue
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Reactive oxygen species (ROS) play an important role in the induction of apoptosis under pathological conditions. Recently, a significant increase in ROS production and disrupted apoptosis mechanisms in keloids have been reported. Nuclear factor erythroid 2-related factor 2 (Nrf2) represents one of the most important cellular defense mechanisms against oxidative stress and is implicated in the regulation of apoptosis. Recently, it has been reported that Nrf2 upregulates Bcl-2, an anti-apoptotic protein. Objective: To compare Nrf2 protein expression in normal skin tissues to keloid tissues. Methods: ROS generation in keloid tissues was evaluated with OxyBlot analysis. Western blotting and/or immunohistochemical staining approaches were used to study expression of Nrf2 or Bcl-2 in keloid and normal skin tissues. Cellular fractionation was performed to examine subcellular distribution of Nrf2. Transfection of fibroblasts with Nrf2-specific small interfering RNA (siRNA) was conducted to understand the relationship between Nrf2 expression and apoptosis induction. Results: Protein oxidation, a marker of oxidative stress, is increased in keloid tissues. Western blot analysis clearly showed that Nrf2 and Bcl-2 are downregulated in keloid tissues. Immunohistochemical staining of Nrf2 confirmed the results of the western blot analysis. Transfection of fibroblasts with the Nrf2-specific siRNA results in increased apoptosis and decreased cell viability. Conclusion: Collectively, our data indicate that Nrf2 expression is downregulated in keloid tissues, and that Nrf2 is involved in the development of apoptosis in Nrf2 siRNA-transfected fibroblasts. We propose that a defective antioxidant system and apoptotic dysregulation may participate in keloid pathogenesis.
Abstract
Background: Reactive oxygen species (ROS) play an important role in the induction of apoptosis under pathological conditions. Recently, a significant increase in ROS production and disrupted apoptosis mechanisms in keloids have been reported. Nuclear factor erythroid 2-related factor 2 (Nrf2) represents one of the most important cellular defense mechanisms against oxidative stress and is implicated in the regulation of apoptosis. Recently, it has been reported that Nrf2 upregulates Bcl-2, an anti-apoptotic protein. Objective: To compare Nrf2 protein expression in normal skin tissues to keloid tissues. Methods: ROS generation in keloid tissues was evaluated with OxyBlot analysis. Western blotting and/or immunohistochemical staining approaches were used to study expression of Nrf2 or Bcl-2 in keloid and normal skin tissues. Cellular fractionation was performed to examine subcellular distribution of Nrf2. Transfection of fibroblasts with Nrf2-specific small interfering RNA (siRNA) was conducted to understand the relationship between Nrf2 expression and apoptosis induction. Results: Protein oxidation, a marker of oxidative stress, is increased in keloid tissues. Western blot analysis clearly showed that Nrf2 and Bcl-2 are downregulated in keloid tissues. Immunohistochemical staining of Nrf2 confirmed the results of the western blot analysis. Transfection of fibroblasts with the Nrf2-specific siRNA results in increased apoptosis and decreased cell viability. Conclusion: Collectively, our data indicate that Nrf2 expression is downregulated in keloid tissues, and that Nrf2 is involved in the development of apoptosis in Nrf2 siRNA-transfected fibroblasts. We propose that a defective antioxidant system and apoptotic dysregulation may participate in keloid pathogenesis.
참고문헌 (40)
- Babu M, "Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing", Mol Cell Biol, 9, pp.1642~1650 (1989)
- Haisa M, "Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF", J Invest Dermatol, 103, pp.560~563 (1994)
- Oliver N, "Fibronectin gene transcription is enhanced in abnormal wound healing", J Invest Dermatol, 99, pp.579~586 (1992)
- Su CW, "The problem scar", Clin Plast Surg, 25, pp.451~465 (1998)
- Appleton I, "Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids", Am J Pathol, 149, pp.1441~1447 (1996)
- Funayama E, "Keratinocytes promote proliferation and inhibit apoptosis of the underlying fibroblasts: an important role in the pathogenesis of keloid", J Invest Dermatol, 121, pp.1326~1331 (2003)
- De Felice B, "Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts", Mol Cell Biochem, 327, pp.191~201 (2009)
- Itoh K, "Regulatory mechanisms of cellular response to oxidative stress", Free Radic Res, 31, pp.319~324 (1999)
- Kensler TW, "Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway", Annu Rev Pharmacol Toxicol, 47, pp.89~116 (2007)
- Lee YJ, "Reactive oxygen species and PI3K", Akt signaling play key roles in the induction of Nrf2-driven heme oxygenase-1expression in sulforaphane-treated human mesothelioma MSTO-211H cells, 2012, pp.50, 116~123
- Magesh S, "Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents", Med Res Rev, 32, pp.687~726 (2012)
- 박선이, "Effects of Xanthium stramarium and Psoralea corylifolia Extracts Combined with UVA1 Irradiation on the Cell Proliferation and TGF-β1 Expression of Keloid Fibroblasts", Annals of Dermatology, 25(3), pp.304~309 (2013), 대한피부과학회
- 손인평, "Pilot Study of the Efficacy of 578 nm Copper Bromide Laser Combined with Intralesional Corticosteroid Injection for Treatment of Keloids and Hypertrophic Scars", Annals of Dermatology, 26(2), pp.156~161 (2014), 대한피부과학회
- Di Virgilio F, "New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets", Curr Pharm Des, 10, pp.1647~1652 (2004)
- Halliwell B, "Free radicals, antioxidants, and human disease: where are we now?", J Lab Clin Med, 119, pp.598~620 (1992)
- Kaspar JW, "Nrf2:INrf2 (Keap1)signaling in oxidative stress", Free Radic Biol Med, 47, pp.1304~1309 (2009)
- Baird L, "The cytoprotective role of the Keap1-Nrf2 pathway", Arch Toxicol, 85, pp.241~272 (2011)
- Itoh K, "An Nrf2", small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements, 1997, pp.236, 313~322
- Itoh K, "Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the aminoterminal Neh2 domain", Genes Dev, 13, pp.76~86 (1999)
- Lyakhovich VV, "Active defense under oxidative stress. The antioxidant responsive element", Biochemistry (Mosc), 71, pp.962~974 (2006)
- Nguyen T, "The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress", Free Radic Biol Med, 37, pp.433~441 (2004)
- Stewart JD, "Control of oxidative stress by the Keap1-Nrf2 pathway", Arch Toxicol, 85, pp.239~ (2011)
- Rada P, "SCF", {beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner, 2011, pp.31, 1121~1133
- Jeong WS, "Nrf2: a potential molecular target for cancer chemoprevention by natural compounds.", Antioxid Redox Signal, 8, pp.99~106 (2006)
- Lau A, "Dual roles of Nrf2 in cancer", Pharmacol Res, 58, pp.262~270 (2008)
- Motohashi H, "Nrf2-Keap1 defines a physiologically important stress response mechanism", Trends Mol Med, 10, pp.549~557 (2004)
- Zhang DD, "Mechanistic studies of the Nrf2-Keap1 signaling pathway", Drug Metab Rev, 38, pp.769~789 (2006)
- Ning JL, "Low- and high-dose hydrogen peroxide regulation of transcription factor NF-E2-related factor 2", Chin Med J (Engl), 123, pp.1063~1069 (2010)
- Greenlund LJ, "Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death", Neuron, 14, pp.303~315 (1995)
- Higuchi M, "Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases", Oncogene, 17, pp.2753~2760 (1998)
- Simon HU, "Role of reactive oxygen species (ROS) in apoptosis induction", Apoptosis, 5, pp.415~418 (2000)
- Desmoulière A, "Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury", Int J Biochem Cell Biol, 29, pp.19~30 (1997)
- Desmoulière A, "Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar", Am J Pathol, 146, pp.56~66 (1995)
- Greenhalgh DG, "The role of apoptosis in wound healing", Int J Biochem Cell Biol, 30, pp.1019~1030 (1998)
- Rockwell WB, "Keloids and hypertrophic scars: a comprehensive review", Plast Reconstr Surg, 84, pp.827~837 (1989)
- Akasaka Y, "Enhanced expression of caspase-3 in hypertrophic scars and keloid: induction of caspase-3 and apoptosis in keloid fibroblasts in vitro", Lab Invest, 80, pp.345~357 (2000)
- Akasaka Y, "Activated caspase expression and apoptosis increase in keloids: cytochrome c release and caspase-9 activation during the apoptosis of keloid fibroblast lines", Wound Repair Regen, 13, pp.373~382 (2005)
- Jiménez B, "Induction of apoptosis in NIH3T3cells after serum deprivation by overexpression of rho-p21, a GTPase protein of the ras superfamily", Oncogene, 10, pp.811~816 (1995)
- Pan H, "The involvement of Nrf2-ARE pathway in regulation of apoptosis in human glioblastoma cell U251", Neurol Res, 35, pp.71~78 (2013)
- Niture SK, "Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis", J Biol Chem, 287, pp.9873~9886 (2012)
